CIDRAP newsletters options
Data released today from a randomized controlled trial evaluating the use of hydroxychloroquine in hospitalized COVID-19 patients show that the antimalaria drug was not associated with reductions in 28-day mortality but was linked with increased time in the hospital and an increased risk of progressing to mechanical ventilation or death.
"The time to ensure that health and essential workers are adequately protected is now," the authors say.
Efforts are under way to use PAHO funds to help nations buy vaccine, and the group is advising them on trial participation.
The only reason to change guidelines is new data and new science, not politics, they say.
Some low- and middle-income countries could see deaths due to HIV, tuberculosis, and malaria spike by as much as 10%, 20%, and 36%, respectively, over the next 5 years because of health service disruptions amid the COVID-19 pandemic and response, according to a modeling study published yesterday in The Lancet Global Health.
The results of a survey sent to pediatric antimicrobial stewardship program (ASP) physicians and pharmacists indicate that most pediatric ASPs conduct antifungal stewardship but many don't feel confident about making antifungal recommendations, US researchers reported today in Infection Control & Hospital Epidemiology.
In both studies, patients receiving tocilizumab had about half the risk of dying.
Los Angeles and San Diego say they will begin the 2020-21 school year online.
With the global total about to top 13 million cases, the WHO warns countries to act.
The Democratic Republic of the Congo's Ebola outbreak in Equateur province has risen to 51 cases, 48 confirmed, and 3 probable, reflecting an increase of 5 since Jul 9.
At a World Health Organization (WHO) media briefing today, Mike Ryan, MD, who leads the group's health emergencies program, said as of Jul 12, 20 deaths have been reported, 17 in confirmed cases and 3 in probable ones.
A multicenter observational study published late last week in The Lancet Child & Adolescent Health identified 78 cases of the pediatric inflammatory multisystem syndrome tied to COVID-19 in the United Kingdom from Apr 1 to May 10—at least 11 times more than expected.
Nearly half of Florida's ICUs are almost full, and more than 20% are completely full.
"We need leadership, community participation, and collective solidarity."
The Centers for Disease Control and Prevention (CDC) said there were 303 additional cases of cyclosporiasis in a multistate outbreak linked to bagged salads sold at major grocery stores.
The CDC said 509 people in eight states have been sickened. Thirty-three people have been hospitalized, but there have been no deaths.
A small study by Italian researchers found that more than 87% of patients who had recovered from acute COVID-19 still had at least one symptom 2 months after illness onset.
The study, published yesterday in a research letter to JAMA, assessed 143 patients treated for acute COVID-19 at a hospital in Rome in April and May. Patients were assessed a mean 60.3 days after onset of the first symptom.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Jul 7
CARB-X announced today that it is awarding $892,000 to Spanish biotechnology company Vaxdyn to develop a vaccine to prevent infections caused by multidrug-resistant bacterial pathogens.
The AMR Action Fund will invest nearly $1 billion in smaller biotech firms.
The WHO posts a brief on transmission and launches a review panel.
Prison cases are 5.5 times higher—and death rates 3 times higher—than in the general population.
"Be mindful of what happens when you open up and throw caution to the wind," Tony Fauci says.
